Literature DB >> 20530738

The metabolic coregulator RIP140: an update.

Asmaà Fritah1, Mark Christian, Malcolm G Parker.   

Abstract

RIP140 is a transcriptional coregulator highly expressed in metabolic tissues where it has important and diverse actions. RIP140-null mice show that it plays a crucial role in the control of lipid metabolism in adipose tissue, skeletal muscle, and the liver and is essential for female fertility. RIP140 has been shown to act as a ligand-dependent transcriptional corepressor for metabolic nuclear receptors such as estrogen-related receptors and peroxisome proliferator-activated receptors. The role of RIP140 as a corepressor has been strengthened by the characterization of RIP140-overexpressing mice, although it emerges through several studies that RIP140 can also behave as a coactivator. Nuclear localization of RIP140 is important for controlling transcription of target genes and is subject to regulation by posttranslational modifications. However, cytoplasmic RIP140 has been shown to play a role in the control of metabolism through direct regulation of glucose transport in adipocytes. In this review, we focus on recent advances highlighting the growing importance of RIP140 as a regulator of energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530738     DOI: 10.1152/ajpendo.00243.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  28 in total

1.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

2.  Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production.

Authors:  Ping-Chih Ho; Kun-Che Chang; Ya-Shan Chuang; Li-Na Wei
Journal:  FASEB J       Date:  2011-02-01       Impact factor: 5.191

Review 3.  Biological activities of receptor-interacting protein 140 in adipocytes and metabolic diseases.

Authors:  Ping-Chih Ho; Li-Na Wei
Journal:  Curr Diabetes Rev       Date:  2012-11

4.  Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor-γ target genes.

Authors:  Noriyuki Yanaka; Mayumi Kanda; Keigo Toya; Haruna Suehiro; Norihisa Kato
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

5.  Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation.

Authors:  Icksoo Lee; Maik Hüttemann; Jenney Liu; Lawrence I Grossman; Moh H Malek
Journal:  J Physiol       Date:  2012-08-06       Impact factor: 5.182

Review 6.  RIP140, a Janus metabolic switch involved in defense functions.

Authors:  Hun Taeg Chung
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

7.  TNIP1 is a corepressor of agonist-bound PPARs.

Authors:  Anthony M Flores; Igor Gurevich; Carmen Zhang; Vincent P Ramirez; Taylor R Devens; Brian J Aneskievich
Journal:  Arch Biochem Biophys       Date:  2011-09-22       Impact factor: 4.013

8.  RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages.

Authors:  Yi-Wei Lin; Pu-Ste Liu; Neeta Adhikari; Jennifer L Hall; Li-Na Wei
Journal:  J Mol Cell Cardiol       Date:  2014-12-18       Impact factor: 5.000

Review 9.  Emerging roles for TNIP1 in regulating post-receptor signaling.

Authors:  Vincent P Ramirez; Igor Gurevich; Brian J Aneskievich
Journal:  Cytokine Growth Factor Rev       Date:  2012-04-28       Impact factor: 7.638

10.  A role for phosphodiesterase 3B in acquisition of brown fat characteristics by white adipose tissue in male mice.

Authors:  Emilia Guirguis; Steven Hockman; Youn Wook Chung; Faiyaz Ahmad; Oksana Gavrilova; Nalini Raghavachari; Yanqin Yang; Gang Niu; Xiaoyuan Chen; Zu Xi Yu; Shiwei Liu; Eva Degerman; Vincent Manganiello
Journal:  Endocrinology       Date:  2013-06-13       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.